Get startedLog in
    Picture of S Biomedics Co logo

    304360 — S Biomedics Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for S Biomedics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:——
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-5,249-5,210-6,337-5,757-6,809
    Depreciation
    Amortisation
    Non-Cash Items1,3902,0701,3211,2653,186
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-877-1,557-2,583-609-2,329
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-3,287-3,205-6,149-3,500-3,981
    Capital Expenditures-490-1,108-1,847-1,675-4,384
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-3,500-5,763-6,976-8,6739,784
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-3,990-6,871-8,824-10,3485,400
    Financing Cash Flow Items75.6853-80911,9086,390
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities4,1618,02012,31816,909173
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-3,057-2,066-2,6563,0741,601